Effect of Suramin on Human Prostate Cancer Cells in Vitro
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Measurement of protein using bicinchoninic acid
1985 • 17,516 citations
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 • 2,447 citations
LNCaP model of human prostatic carcinoma.
1983 • 1,749 citations
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1979 • 1,595 citations
Isolation of a human prostate carcinoma cell line (DU 145)
1978 • 1,176 citations
Purification of a Human Prostate Specific Antigen
2016 • 844 citations
A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.
1985 • 752 citations
PURIFICATION OF HUMAN PROSTATE SPECIFIC ANTIGEN
1979 • 547 citations
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells
1987 • 387 citations
Suramin: an anticancer drug with a unique mechanism of action.
1989 • 370 citations
Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture.
1984 • 315 citations
Suramin: With Special Reference to Onchocerciasis
1978 • 291 citations
Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.
1981 • 208 citations
Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids
1988 • 139 citations
Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection
1986 • 138 citations
Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines.
1988 • 95 citations
Antiproliferative effects of suramin on lymphoid cells.
1987 • 89 citations
Suramin in Adrenal Cancer: Modulation of Steroid Hormone Production, Cytotoxicityin Vitro, and Clinical Antitumor Effect*
1990 • 87 citations
Measurement of prostate-specific antigen by radioimmunoassay.
1984 • 80 citations
Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.
1980 • 79 citations
The Effect of Serum Prolactin on Plasma Adrenal Androgens and the Production and Metabolic Clearance Rate of Dehydroepiandrosterone Sulfate in Normal and Hyperprolactinemic Subjects
1986 • 71 citations
Use of Suramin in Treatment of Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation
1991 • 60 citations
The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer
1989 • 57 citations
Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro.
1989 • 54 citations
Quantification of Suramin by Reverse-Phase Ion-Pairing High-Performance Liquid Chromatography
1985 • 44 citations
Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus Monkey
1987 • 41 citations
Immunochemical evaluation of the organ specificity of prostatic acid phosphatase.
1981 • 41 citations
The Partial Dependency of Human Prostatic Growth Factor on Steroid Hormones in Stimulating Thymidine Incorporation into Dna
1987 • 32 citations
Cited By (0)
No citing papers found in database